IP Library › Granted Patent US 9,695,189
Granted Patent B2
US 9,695,189 · App. 13/782,584 · Granted Jul 4, 2017

Chemical crosslinkers and compositions thereof

Inventor: Mark Quang Nguyen (San Jose, CA)
Assignee: Mark Quang Nguyen
C07D495/04C07C329/06C07D207/452C07D207/46C07D233/32C07D403/12C07D405/12C07D493/04C07C2601/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,695,189
App. No.
13/782,584
Granted
Jul 4, 2017
Kind
B2
Abstract

Cleavable crosslinkers of Formula (I) useful reagents in biochemical drug research and development such as antibody drug conjugates are disclosed.

Claims (27)

1. A compound of Formula (I):

or a salt thereof, wherein:

A 1 is a moiety selected from Formula (A 1 a1), Formula (A 1 a2), Formula (A 1 a3), Formula (A 1 a4), Formula (A 1 b1), Formula (A 1 b3), Formula (A 1 b4), Formula (A 1 c1), Formula (A 1 c2), Formula (A 1 c3), Formula (A 1 d1), Formula (A 1 d2), Formula (A 1 d3), Formula (A 1 d4), Formula (A 1 d5), Formula (A 1 d6), Formula (A 1 d7), Formula (A 1 d8), Formula (A 1 e1), Formula (A 1 e2), Formula (A 1 f1), Formula (A 1 f2), Formula (A 1 f3), Formula (A 1 f4), and Formula (A 1 f5):

wherein:

each R 8 and R 9 is independently selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, and phenyl;

each E is selected from F, Cl, Br, and I; and

each L 2 is selected from hydroxysuccinimidyl, phenol yl, substituted phenol yl, hydroxybenzotriazolyl, F, Cl, Br, N-hydroxysuccinimidyl, sulfo-N-hydroxysuccinimidyl, 4-nitrophenol-yl, pentafluorophenol-yl, 4-methylsulfonylphenol-yl, hydroxybenzotriazolyl, 1-hydroxy-7-azabenzotriazolyl, trichlorophenol-yl, and imidazolyl;

X 1 and X 3 are independently selected from a covalent bond, C 1-20 alkanediyl, substituted C 1-20 alkanediyl, C 1-20 heteroalkanediyl, substituted C 1-20 heteroalkanediyl, C 3-12 cycloalkanediyl, substituted C 3-12 cycloalkanediyl, C 3-12 heterocycloalkanediyl, substituted C 3-12 heterocycloalkanediyl, C 4-20 alkanecycloalkanediyl, substituted C 4-20 alkanecycloalkanediyl, C 4-20 heteroalkanecycloalkanediyl, substituted C 4-20 heteroalkanecycloalkanediyl, C 6-20 arenediyl, substituted C 6-20 arenediyl, C 6-20 heteroarenediyl, substituted C 6-20 heteroarenediyl, C 7-20 alkanearenediyl, substituted C 7-20 alkanearenediyl, C 6-20 heteroalkanearenediyl, substituted C 6-20 heteroalkanearenediyl, and —(CH 2 ) n1 —(CH 2 —CH 2 —O) n2 —(CH 2 )— 3 —, wherein:

each n1 and n3 is independently an integer selected from 0 to 5; and

each n2 is independently an integer selected from 1 to 25;

X 2 is selected from a covalent bond, —O—, —S—, —NH—, —N═, —N═N—, —N═CH—, —SO—, —SO 2 —,—SO 2 NH—, —SS—, —C(O)—, —C(O)O—, —C(O)NH—, —C(O)S—, —C(O)NH—N═, —OP(O)OH)O—, —OC(O)O—, —OC(O)NH—, —NHC(O)NH—, and —NHC(S)NH—;

R 1 and R 2 are independently selected from hydrogen, C 1-6 alkyl, substituted C 1-6 alkyl, C 1-6 heteroalkyl, substituted C 1-6 heteroalkyl, C 6-10 aryl, substituted C 6-10 aryl, C 6-10 heteroaryl, and substituted C 6-10 heteroaryl; and

L 1 is selected from F, Cl, Br, N-hydroxysuccinimidyl, sulfo-N-hydroxysuccinimidyl, 4-nitrophenol-yl, pentafluorophenol-yl, 4-methylsulfonylphenol-yl, hydroxybenzotriazolyl, 1-hydroxy-7-azabenzotriazolyl, trichlorophenol-yl, and imidazolyl;

provided that compounds falling within the following scopes of the Formula (I) are excluded:

(1) A 1 is (A 1b 3), X 2 is a covalent bond, one of R 1 and R 2 is hydrogen and the other is substituted C 1-6 alkyl, L 1 is 4-nitrophenol-yl, X 1 is substituted C 1-20 alkanediyl and X 3 is a covalent bond;

(2) A 1 is (A 1 a2), R 8 is hydrogen, X 2 is a covalent bond, R 1 and R 2 are hydrogen, L 1 is 4-nitrophenol-yl, X 3 is substituted C 1-20 alkanediyl and X 1 is a covalent bond;

(3) A 1 is (A 1 b1), L2 is Cl, R 1 and R 2 are hydrogen, L 1 is Cl, X 2 is a covalent bond, X 3 is C 1-20 alkanediyl, and X 1 is substituted C 1-20 heteroalkanediyl;

(4) A 1 is (A 1 a3), E is F, one of R 1 and R 2 is hydrogen and the other is substituted C 1-6 alkyl, L 1 is Cl, X 3 is a covalent bond, X 2 is —O— and X 1 is substituted C 4-20 heteroalkanecycloalkanediyl; and

(5) A 1 is (A 1 b1), L 2 is Cl, R 1 and R 2 are hydrogen, L is Cl, X 3 is C 6-20 arenediyl, X 2 is —C(O)—, and X 1 is C 1-20 heteroalkanediyl.

2. The compound of claim 1 , wherein A 1 is a moiety selected from Formula (A 1 a1-1), Formula (A 1 a2-1), Formula (A 1 a3-1), Formula (A 1 a4), Formula (A 1 b1-1), Formula (A 1 b3), Formula (A 1 b4), Formula (A 1 c1), Formula (A 1 c2), Formula (A 1 c3), Formula (A 1 d1), Formula (A 1 d2), Formula (A 1 d3), Formula (A 1 e1), Formula (A 1 e2), Formula (A 1 f1), Formula (A 1 f3), Formula (A 1 f4), and Formula (A 1 f5):

3. The compound of claim 1 , wherein X′ is selected from a covalent bond, methane-diyl, ethane-diyl, propane-diyl, butane-diyl, pentane-diyl, hexane-diyl, cyclopropane-diyl, cyclobutane-diyl, cyclopentane-diyl, cyclohexane-diyl, methylcyclohexane-diyl, benzene-diyl, methylbenzene-diyl, ethylbenzene-diyl, propylbenzene-diyl, butylbenzene-diyl, and —(CH 2 ) n1 —(CH 2 —CH 2 —O) 1 —(CH 2 )— 3 —, wherein each n1 and n3 is independently an integer selected from 0 to 5 and n2 is an integer selected from 1 to 25.

4. The compound of claim 1 , wherein X 2 is selected from a covalent bond, —O—, —S—, —SO—, —SO 2 —, —SO 2 NH—, —SS—, —C(O)—, —C(O)O—, —C(O)NH—, —C(O)NH—N═, —OC(O)NH—, and —NHC(O)NH—.

5. The compound of claim 1 , wherein X 3 is selected from a covalent bond, methane-diyl, ethane-diyl, propane-diyl, butane-diyl, pentane-diyl, hexane-diyl, cyclopropane-diyl, cyclobutane-diyl, cyclopentane-diyl, cyclohexane-diyl, methylcyclohexane-diyl, benzene-diyl, methylbenzene-diyl, ethylbenzene-diyl, propylbenzene-diyl, butylbenzene-diyl, and —(CH 2 ) n1 —(CH 2 —CH 2 —O) n2 —(CH 2 ) n3 —, wherein each n1 and n3 is independently an integer selected from 0 to 5 and n2 is an integer selected from 1 to 25.

6. The compound of claim 1 , wherein R 1 and R 2 are independently selected from hydrogen, methyl, ethyl, propyl, isopropyl, and phenyl.

7. The compound of claim 1 , wherein L 1 is selected from Cl, N-hydroxysuccinimidyl, sulfo-N-hydroxysuccinimidyl, 4-nitrophenol-yl, and pentafluorophenol-yl.

8. The compound of claim 1 , wherein the compound is selected from (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 2-(2,5-dioxopyrrol-1-yl)acetate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 3-(2,5-dioxopyrrol-1-yl)propanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-(2,5-dioxopyrrol-1-yl)butanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 5-(2,5-dioxopyrrol-1-yl)pentanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-(2,5-dioxopyrrol-1-yl)hexanoate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 6-(2,5-dioxopyrrol-1-yl)hexanoate; [1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxy-2-methyl-propyl] 6-(2,5-dioxopyrrol-1-yl)hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[6-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]hexanoylamino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarboxylate; [1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxy-2-methyl-propyl] 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarboxylate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 3-(2,5-dioxopyrrol-1-yl)benzoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-(2,5-dioxopyrrol-1-yl)benzoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-[4-(2,5-dioxopyrrol-1-yl)phenyl]butanoate; O4-(2,5-dioxopyrrolidin-1-yl) O1-[(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl] butanedioate; (4-nitrophenoxy)carbonyloxymethyl 5-[(4S)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 5-(5-methyl-2-oxo-imidazolidin-4-yl)pentanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[5-(5-methyl-2-oxo-imidazolidin-4-yl)pentanoylamino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 5-[(4S)-2,5,5-trioxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[5-[(4S)-2,5,5-trioxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 2-methylprop-2-enoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-(2-methylprop-2-enoylamino)hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl prop-2-ynoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-(prop-2-ynoylamino)hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 3-(3-methyldiazirin-3-yl)propanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[3-(3-methyldiazirin-3-yl)propanoylamino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-(7-oxofuro[3,2-g]chromen-9-yl)oxybutanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 2-vinyl sulfonylacetate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[(2-vinylsulfonylacetyl)amino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[(2-bromoacetyl)amino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-azidohexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-(6-azidohexanoylamino)hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-azidobenzoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[(4-azidobenzoyl)amino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-azido-2-nitro-benzoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[(4-azido-2-nitro-benzoyl)amino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 4-azido-2-hydroxy-benzoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[(4-azido-2-hydroxy-benzoyl)amino]hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 2-(7-azido-4-methyl-2-oxo-chromen-3-yl)acetate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 6-[[2-(7-azido-4-methyl-2-oxo-chromen-3-yl)acetyl]amino] hexanoate; (4-nitrophenoxy)carbonyloxymethyl 6-(2,5-dioxopyrrol-1-yl)hexanoate; (2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl 3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoate; O4-(2,5-dioxopyrrolidin-1-yl) O1-[(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl] butanedioate; (4-nitrophenoxy)carbonyloxymethyl 5-(5-methyl-2-oxo-imidazolidin-4-yl)pentanoate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[(prop-2-ynoylamino)methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[3-(3-methyldiazirin-3-yl)propanoylamino]methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[4-(7-oxofuro[3,2-g]chromen-9-yl)oxybutanoylamino]methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[(2-vinylsulfonylacetyl)amino]methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[(2-bromoacetyl)amino]methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[(6-azidohexanoylamino)methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[(4-azidobenzoyl)amino]methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[[2-(7-azido-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]methyl]cyclohexanecarboxylate; 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[5-(5-methyl-2-oxo-imidazolidin-4-yl)pentanoylamino]methyl]cyclohexanecarboxylate; and 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[[5-[(4S)-2,5,5-trioxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]methyl]cyclohexanecarboxylate; or a salt of any of the foregoing.

9. The compound 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethyl 4-[(3-methylbut-2-enoylamino)methyl]cyclohexanecarboxylate.

Continuity (1)
Related Publication 20140249319A1 · Sep 4, 2014